AN2 Therapeutics, Inc. (ANTX)

3.78 +0.16 (+4.42%) USD  |  NASDAQ  |  Apr 21, 16:00
3.80 +0.02 (+0.53%) After-Hours: 19:49
More

AN2 Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade